Lv4
422 积分 2026-03-02 加入
A brain metastasis prediction model in women with breast cancer
2个月前
已完结
Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer
2个月前
已完结
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
3个月前
已完结
FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer
3个月前
已关闭
Prevalence of HER2 low in breast cancer subtypes using the VENTANA anti-HER2/neu (4B5) assay
3个月前
已完结
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer
3个月前
已完结
Trop2-targeted therapy in breast cancer
3个月前
已完结
A Review of Current and Future Antibody Drug Conjugates in Breast Cancer
5个月前
已完结
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
5个月前
已完结
Why does EGFR-targeted therapy continue to fail in breast cancer? From mechanistic deciphering to novel intervention strategies
5个月前
已完结
皖公网安备34019202002308
